4.8 Article

Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy

Related references

Note: Only part of the references are listed.
Review Chemistry, Multidisciplinary

Cellular Nanosponges for Biological Neutralization

Shuyan Wang et al.

Summary: Cellular nanosponges, as host decoys, have shown great potential for biological neutralization applications. By mimicking susceptible host cells, they can create function-driven and broad-spectrum neutralization solutions against various pathological agents.

ADVANCED MATERIALS (2022)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Review Biochemistry & Molecular Biology

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions

Ming Yi et al.

Summary: Antibodies targeting PD-1/PD-L1 revive immune response against cancer cells, but the low response rate calls for combination therapies. Combining with chemotherapy, radiotherapy, and other treatments can achieve better outcomes, and individualized combination selection is needed to overcome treatment resistance.

MOLECULAR CANCER (2022)

News Item Biotechnology & Applied Microbiology

Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape

Samik Upadhaya et al.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Oncology

Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials

Dhananj ay Yadav et al.

Summary: Cancer is the second leading cause of death worldwide. Traditional approaches like surgery, chemotherapy, and radiotherapy have been commonly used for cancer treatment. Cancer immunotherapy, a novel therapeutic modality, boosts the immune responses of patients against malignancy. Recent advances in nanotechnology have facilitated the development of successful and efficient anticancer drug systems based on nanoparticles.

SEMINARS IN CANCER BIOLOGY (2022)

Review Immunology

Resistance Mechanisms to Anti-PD Cancer Immunotherapy

Matthew D. Vesely et al.

Summary: The success of anti-PD therapy has revolutionized cancer treatment, but the resistance mechanisms and heterogeneity of responses remain poorly understood. This review discusses recent human cancer data that reveal mechanisms of resistance to anti-PD therapy, including immune-based resistance mechanisms and emerging mechanisms such as alterations in metabolism, microbiota, and epigenetics. Strategies to overcome resistance and the importance of developing additional immunotherapies are also highlighted.

ANNUAL REVIEW OF IMMUNOLOGY (2022)

Article Engineering, Biomedical

Engineered nanomaterials for synergistic photo-immunotherapy

Ranran Guo et al.

Summary: Nanomaterial-synergized photodynamic therapy and photothermal therapy have significant advantages in fighting cancer. Researchers are now focusing on combining these therapies with immunotherapy by using nanomaterials to promote the maturation of immune cells and infiltration of immune cells, aiming to improve the treatment effectiveness.

BIOMATERIALS (2022)

Review Chemistry, Multidisciplinary

Advancements in cell membrane camouflaged nanoparticles: A bioinspired platform for cancer therapy

Namdev Dhas et al.

Summary: The idea of using natural cell membranes as a coating for nanoparticles is a promising approach that gives man-made vectors natural capabilities and advantages. These biomimetic nanoparticles retain the physicochemical properties of the nanoparticles while also having the functionality of source cell membranes. They have been used for drug delivery, immune evasion, imaging, cancer-targeting, and phototherapy sensitivity. Various methods have been reported for reengineering the surface of nanoparticles using biological membranes, and cell-membrane-based biohybrid delivery systems have gained interest as therapeutic delivery systems due to their low immunogenicity and biomimetic properties.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Pharmacology & Pharmacy

Materials and device design for advanced phototherapy systems

Ju Seung Lee et al.

Summary: Phototherapy has emerged as a promising solution for cancer treatment due to its multifunctionality and minimal invasiveness. This review focuses on diverse optical electronics and phototherapy methods, including photo-thermal therapy, photo-activated chemotherapy, and photo-dynamic therapy. The introduction of a drug delivery system that can deliver photopharmaceutical agents to the tumor site is also discussed. The article provides an overview of materials and devices for phototherapy and addresses critical issues and limitations.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Oncology

Exploring immunotherapy in colorectal cancer

Junyong Weng et al.

Summary: Immunotherapy with immune checkpoint blockade has shown progress in the treatment of metastatic colorectal cancer (mCRC), although its effectiveness is limited. This review summarizes treatment strategies, discusses the mechanism and application of immune checkpoint blockade in mCRC treatment, and provides the latest research and clinical trial results.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Medicine, General & Internal

PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer

Andrea Cercek et al.

Summary: This study found that mismatch repair-deficient, locally advanced rectal cancer is highly sensitive to PD-1 blockade. Additionally, no adverse events of grade 3 or higher have been reported, and no cases of progression or recurrence have been observed. Longer follow-up is needed to assess the duration of response.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Review Biology

The distinguishing electrical properties of cancer cells

Elisabetta Di Gregorio et al.

Summary: In recent decades, medical research has primarily focused on the genetic aspect of cancer, neglecting the influence of other electrical changes on cancer development. Understanding the electrical behavior of cancer cells is crucial in combating cancer.

PHYSICS OF LIFE REVIEWS (2022)

Review Oncology

Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

Marilyne Labrie et al.

Summary: Normal and cancer cells utilize adaptive responses to survive environmental stresses, and this Review discusses how tumor ecosystems adapt to therapeutic stresses and how these adaptations can be exploited to overcome cancer therapy resistance.

NATURE REVIEWS CANCER (2022)

Article Engineering, Biomedical

Ag2S nanoparticle-mediated multiple ablations reinvigorates the immune response for enhanced cancer photo-immunotherapy

Ruxia Han et al.

Summary: Photothermal therapy (PTT) using water-soluble Ag2S nanoparticles (NPs) has shown promising results in cancer treatment. Studies have found that multiple PTT cycles with Ag2S NPs can inhibit primary tumor cell proliferation, reduce tumor recurrence, and alleviate metastasis by stimulating the immune response in a mouse breast cancer model.

BIOMATERIALS (2021)

Review Oncology

Immunomodulation by targeted anticancer agents

Giulia Petroni et al.

Summary: Targeted anticancer agents are designed to inhibit specific molecular alterations that support oncogenesis or tumor progression, but they may also have immunomodulatory effects that can influence therapeutic efficacy. Harnessing these effects could potentially lead to superior clinical outcomes.

CANCER CELL (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Chemistry, Multidisciplinary

Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy

Fatemeh Oroojalian et al.

Summary: Nanotechnology offers promising opportunities for cancer management, particularly through biomimetic approaches using immune cell membranes to coat nanoparticles for improved stability and targeting; the surface proteins from immune cells can provide various functionalities to nanoparticles, enhancing their efficacy and reducing toxicity.

SMALL (2021)

Article Toxicology

Cellular uptake and toxicity of gold nanoparticles on two distinct hepatic cell models

Maria Enea et al.

Summary: The study compared the cytotoxic effects of gold nanoparticles with different size, shape, and capping on liver cells, finding that smaller 15 nm spheres displayed the highest toxicity. Toxicological effects were influenced by capping, size, and cell type, with citrate-capped nanoparticles more toxic than MUA, 15 nm nanoparticles more toxic than 60 nm ones, and primary rat hepatocytes more sensitive than HepaRG cells. The presence of FBS significantly influenced toxicity outcomes, with higher internalization of AuNPs in PRH compared to HepaRG cells.

TOXICOLOGY IN VITRO (2021)

Article Chemistry, Multidisciplinary

Immunosuppressive Nanoparticles for Management of Immune-Related Adverse Events in Liver

Shufang Shen et al.

Summary: The study developed immunosuppressive nanoparticles by coating PD-L1 overexpressed MSCs plasma membrane on PLGA nanoparticles, aiming to reduce irAEs caused by immune checkpoint inhibitors. These nanoparticles showed potential in rescuing hepatitis in a clinically relevant mouse model without affecting the efficiency of ICB therapy in inhibiting tumor growth.

ACS NANO (2021)

Article Biotechnology & Applied Microbiology

Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19

Tianchuan Zhu et al.

Summary: The study demonstrates that nanovesicles derived from bispecific CAR-T cells can effectively target SARS-CoV-2, neutralize the virus, prevent viral resistance and antibody-dependent enhancement effects, and facilitate targeted delivery of antiviral drugs to infection sites, reducing adverse reactions.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Multidisciplinary Sciences

Lure-and-kill macrophage nanoparticles alleviate the severity of experimental acute pancreatitis

Qiangzhe Zhang et al.

Summary: The study presents a novel nanotherapeutic approach for treating acute pancreatitis by using macrophage membrane-coated nanoparticles, which effectively reduce inflammation and tissue damage associated with the disease.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Genetically engineered cell membrane-coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs

Joon Ho Park et al.

Summary: By exploiting the specific affinity between VLA-4 and VCAM-1, a biomimetic nanoparticle formulation capable of targeting inflammation sites was developed. These nanoparticles coated with cell membranes showed enhanced affinity to target cells, improving the delivery of anti-inflammatory drugs to inflamed lungs and demonstrating significant therapeutic efficacy in vivo.

SCIENCE ADVANCES (2021)

Review Biochemistry & Molecular Biology

Immunotherapy in colorectal cancer: current achievements and future perspective

Ahui Fan et al.

Summary: Immunotherapy has shown significant progress in treating colorectal cancer, with the approval of two PD-1 antibodies and successful outcomes in first-line treatment reported in the past two years. Attention is also paid to predictive biomarkers for immunotherapy, with promising results in different types of colorectal cancer treatments.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Oncology

Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion

Suchit Jhunjhunwala et al.

Summary: This review discusses the importance of antigen presentation in the success of immune checkpoint inhibition therapy and mechanisms by which tumors evade immune recognition. Tumors evade immune recognition by modulating antigen expression and altering antigen presentation.

NATURE REVIEWS CANCER (2021)

Review Chemistry, Multidisciplinary

Emerging combination strategies with phototherapy in cancer nanomedicine

Zhongjian Xie et al.

CHEMICAL SOCIETY REVIEWS (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

Tumour-intrinsic resistance to immune checkpoint blockade

Anusha Kalbasi et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Chemistry, Multidisciplinary

Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy

Xiaopin Duan et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)

Review Chemistry, Multidisciplinary

Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer

Yijing Liu et al.

CHEMICAL SOCIETY REVIEWS (2019)

Review Medicine, General & Internal

Colorectal cancer

Evelien Dekker et al.

LANCET (2019)

Article Multidisciplinary Sciences

Statistical determination of synergy based on Bliss definition of drugs independence

Eugene Demidenko et al.

PLOS ONE (2019)

Article Chemistry, Multidisciplinary

Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)

Xudong Zhang et al.

ADVANCED MATERIALS (2018)

Review Chemistry, Multidisciplinary

Cell Membrane Coating Nanotechnology

Ronnie H. Fang et al.

ADVANCED MATERIALS (2018)

Review Immunology

Regulation and Function of the PD-L1 Checkpoint

Chong Sun et al.

IMMUNITY (2018)

Article Biochemistry & Molecular Biology

Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas

Christopher W. Mount et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer

Jutaek Nam et al.

NATURE COMMUNICATIONS (2018)

Review Medicine, General & Internal

Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis

Shrujal Baxi et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Review Medicine, General & Internal

Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis

Shrujal Baxi et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Article Multidisciplinary Sciences

Elimination of established tumors with nanodisc-based combination chemoimmunotherapy

Rui Kuai et al.

SCIENCE ADVANCES (2018)

Article Engineering, Biomedical

Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications

Anna Wozniak et al.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE (2017)

Article Multidisciplinary Sciences

Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management

Soracha Thamphiwatana et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Engineering, Biomedical

The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems

Alexandre Albanese et al.

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 14 (2012)

Article Medicine, Research & Experimental

Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry

Zhili Zheng et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)